Welcome to our dedicated page for ASSURE HLDGS news (Ticker: IONM), a resource for investors and traders seeking the latest updates and insights on ASSURE HLDGS stock.
Assure Holdings Corp. (NASDAQ: IONM) is a leading provider of intraoperative neuromonitoring (IONM) and remote neurology services, based in Denver, Colorado. The company collaborates with neurosurgeons and orthopedic spine surgeons to offer a comprehensive suite of services that ensure the safety and integrity of the nervous system during invasive surgical procedures.
Assure Holdings employs a skilled team of technologists and utilizes state-of-the-art monitoring equipment to provide real-time feedback to surgeons during operations. Their services are crucial in procedures where the nervous system is at risk, including neurosurgery, spine, cardiovascular, orthopedic, and ear, nose, and throat surgeries. By managing 100% of the intraoperative neuromonitoring scheduling and setup, Assure ensures seamless integration into the surgical workflow.
The company is accredited by The Joint Commission, underscoring its commitment to delivering exceptional surgical care and a positive patient experience. Assure's mission revolves around a patient-driven focus, ensuring the highest quality service in the industry.
In recent developments, Assure Holdings has expanded its authorized shares from 9,000,000 to 250,000,000, enabling the company to raise capital and execute its strategic plans. Additionally, Assure is set to complete a significant transaction with Danam Health Inc., which will further bolster its market position and operational capabilities. The company has been granted an extension by the Nasdaq Listing Qualifications Panel to regain compliance with the continued listing requirements by July 22, 2024.
For more information, visit the company’s website at www.assureneuromonitoring.com.
Assure Holdings Corp. (NASDAQ: IONM) announced a cost reduction plan aimed at achieving EBITDA profitability and positive cash flow, targeting over $2.0 million in annual savings. The plan includes a $1.0 million reduction in salaries and a $1.0 million decrease from staff headcount. Additionally, Assure aims to boost revenue by eliminating legacy revenue sharing agreements, expecting a monthly revenue increase of over $200,000 in 2023. These measures build on over $4.0 million in savings implemented in 2022, including workforce reductions and market rationalization. The company is focused on sustainable growth and improving operational efficiencies.
Assure Holdings Corp. (NASDAQ: IONM) has completed the acquisition of Neuroprotect Neuromonitoring, LLC, significantly expanding its intraoperative neuromonitoring (IONM) services in Colorado. The acquisition, finalized on December 31, 2022, includes assets such as accounts receivable and material contracts. In 2022, NervePro conducted approximately 750 IONM managed cases. Assure aims to enhance revenue from these acquired operations and strengthen its market presence. The transaction involved the issuance of 1.5 million shares at a price of $0.26 each, with Assure planning to register these shares for resale.
Assure Holdings Corp. (NASDAQ: IONM) announced that all matters presented at its annual general meeting on December 28, 2022, received shareholder approval. Key decisions included the election of five board members: Martin Burian, John Farlinger, Christopher Rumana, Steven Summer, and John Flood, as well as the ratification of Baker Tilly US as the company's auditors for the fiscal year ending December 31, 2022. The meeting's outcomes are detailed in the Proxy Statement dated December 2, 2022.
Assure Holdings Corp. (NASDAQ: IONM) announced its participation in two investor conferences in December 2022. Management will engage in one-on-one meetings at the Benchmark Discovery One-on-One Investor Conference on December 1 and the Roth Capital Deer Valley Conference on December 15-16. Assure specializes in intraoperative neuromonitoring and remote neurology services, providing clinical support during high-risk surgeries. The company emphasizes patient safety and real-time monitoring during procedures, aiming to deliver exceptional surgical care.
Assure Holdings Corp. (NASDAQ: IONM) reported its Q3 2022 financial results, showing gross revenue of $8.3 million, down from $8.5 million in Q3 2021, and a net revenue of $6.2 million, also lower than $8.5 million year-over-year. Adjusted EBITDA was negative at $(1.2) million compared to $1.2 million in the prior year. Despite a challenging environment, the company seeks to enhance margins, expecting to manage between 21,000 and 22,000 cases in FY 2022. Actions taken include exiting underperforming markets and initiating cost reductions, aiming for over $5 million in annual savings.
Assure Holdings Corp. (NASDAQ: IONM) announced that shareholders recorded by November 18, 2022, can vote at the Annual Meeting set for December 28, 2022. The notice will be mailed around November 28, 2022. Assure is a leading provider of intraoperative neuromonitoring and remote neurology services, supporting various surgical procedures while ensuring patient safety and care. The company emphasizes its commitment to exceptional surgical outcomes and patient experiences, backed by a team of trained technologists and accredited operations.
Assure Holdings Corp. (NASDAQ: IONM) will host a conference call on November 14, 2022, at 4:30 p.m. Eastern Time to discuss its third-quarter financial results for the period ending September 30, 2022. The live webcast and related presentation can be accessed through their investor relations website. A replay will be available after the call until November 28, 2022. Assure is a leading provider of intraoperative neuromonitoring and remote neurology services, focusing on surgical safety and patient care in high-risk procedures.
Assure Holdings Corp. (NASDAQ: IONM) has announced its first intraoperative neuromonitoring case in New Jersey. This expansion aligns with their strategy to grow in the Northeast, targeting states with favorable reimbursement profiles. Dr. Marc J. Levine, a prominent orthopedic surgeon, will work with Assure, emphasizing their strong reputation and robust Quality Assurance program. Assure continues to focus on organic growth and exceptional clinical care to enhance patient outcomes.
Assure Holdings Corp. (NASDAQ: IONM) announced participation in multiple investor conferences in October 2022, focusing on intraoperative neuromonitoring and remote neurology services. Key events include the Roth Healthcare Opportunities Conference on October 6 in New York, the MicroCap Rodeo Windy City Roundup on October 12-13 in Chicago, and the LD Micro Main Event on October 25-26 in Los Angeles. Additionally, Assure will attend the ThinkEquity Conference on October 26 in New York. Presentations and one-on-one meetings with investors are scheduled. For more details, visit their website.
Assure Holdings Corp. (NASDAQ: IONM) successfully completed a $6.2 million underwritten public offering, with Aegis Capital Corp. serving as the sole bookrunner. The company provides intraoperative neuromonitoring surgical support services across multiple U.S. states, primarily focusing on spine and head surgeries. Proceeds from the offering are expected to enhance operational capabilities and support growth initiatives. This strategic move positions Assure Holdings for future expansion within the neuromonitoring industry.
FAQ
What is the current stock price of ASSURE HLDGS (IONM)?
What is the market cap of ASSURE HLDGS (IONM)?
What is Assure Holdings Corp.?
What services does Assure Holdings provide?
In which types of surgeries does Assure Holdings offer its services?
Where is Assure Holdings based?
What recent achievements has Assure Holdings made?
Is Assure Holdings accredited?
How does Assure Holdings ensure quality during surgeries?
What is the mission of Assure Holdings?
How can I find more information about Assure Holdings?
What are the next steps for Assure Holdings regarding its Nasdaq listing?
